Innovation of Iglarlexi in Intensification
Prof. Abdulrahman Al Sheikh, consultant endocrinology and diabetes, presenting the first head-to-head comparison of iGlarLixi and premix insulin.
![](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-sa/new/events/images/image-(53).jpg/jcr:content/image%20(53).jpg)
![](/dam/jcr:505d0dcf-369b-48db-9026-76b1d46aac8a/SGGDC-115%20-%20Dia-Tour%20Banner_v2-02.webp)
Related articles
MAT-BH-2200601/v1/August 2022
Prof. Abdulrahman Al Sheikh, consultant endocrinology and diabetes, presenting the first head-to-head comparison of iGlarLixi and premix insulin.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.